Importantly, cancer-derived SPOP mutations disrupted the binding between SPOP and HDAC6 and failed to promote HDAC6 poly-ubiquitination and subsequently degradation (Figure 5), which might lead to elevated levels of HDAC6 to promote tumorigenesis. This evidence concerns the gene HDAC6 and cancer.